Exact Sciences (EXAS) Inventory Turnover Ratio, from fourth quarter 2025 to fourth quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Exact Sciences Corporation  (NASDAQ: EXAS)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Exact Sciences Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Exact Sciences Corporation inventory turnover ratio, the Exact Sciences Corporation's ability to sell and replace its inventory in the fourth quarter 2025, sequentially increased to 5.8 in the fourth quarter 2025, EXAS's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Exact Sciences in Dec 31 2025 quarter, has decreased to 63 days, compare to 66 days, in the Sep 30 2025 quarter.

Within Healthcare sector 71 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2025, to 159, from total ranking in the third quarter 2025 at 421.

EXAS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Exact Sciences Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EXAS Inventory Turnover Ratio (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Inventory Growth 2.35 % 20.29 % 34.64 % 37.38 % 27.38 %
Y / Y Cost of Sales Growth 19.55 % 35.67 % 30.63 % 21.1 % 14.44 %
Inventory Turnover Ratio (TTM) 5.8 5.57 5.38 5.39 5.6
EXAS's Total Ranking # 159 # 421 # 421 # 493 # 269
Average inventory processing period 63 65 68 68 65
Seq. Inventory Growth 0.86 % -3.92 % -2.87 % 8.74 % 18.54 %
Seq. Cost of Sales Growth -0.75 % 7.26 % 20.39 % -6.72 % 12.63 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 72
Overall Market # 159

Inventory Turnover Ratio Statistics
High Average Low
7.02 4.77 2.96
(Jun 30 2017)   (Jun 30 2015)



EXAS Company Profile >> Back to EXAS Efficiency Comparisons >> Compare EXAS Inventory Turnover Ratio to its Competitors

Financial Statements
Exact Sciences's Inventories $ 166 Millions Visit EXAS's Balance sheet
Exact Sciences's Cost of Revenues TTM $ 984 Millions Visit EXAS's Income Statement
What are EXAS's Sales? Visit EXAS's Sales by Segment

Other Inventory Turnover Ratios
Exact Sciences's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EXAS's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EXAS's Competitors
Inventory Turnover Ratio for EXAS's Suppliers
Inventory Turnover Ratio for EXAS's Customers

You may also want to know
EXAS's Sales Growth Rates EXAS's Pe Price to earnings ratio EXAS's Receivables Turnover Ratio EXAS's Stock Quote
EXAS's Net Income Growth Rates EXAS's Ps Price to Sales ratio EXAS's Sales per Employee EXAS's Asset Turnover Ratio
EXAS's Net Margin EXAS's Pb Price to Book ratio EXAS's Financial Strength Ratios EXAS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2025 Inventories at quarter ending Dec 31 2025
Precipio inc   14.80 $ 13.343  Millions$ 1  Millions
Newgenivf Group Limited  13.92 $ 3.771  Millions$ 0  Millions
Rockwell Medical inc   13.74 $ 57.000  Millions$ 4  Millions
Natera Inc   13.62 $ 809.395  Millions$ 59  Millions
The Oncology Institute Inc   12.87 $ 205.502  Millions$ 16  Millions
Cryo cell International Inc   11.94 $ 7.377  Millions$ 1  Millions
Irhythm Holdings Inc   11.85 $ 219.000  Millions$ 18  Millions
Edap Tms Sa  11.73 $ 95.511  Millions$ 8  Millions
Infusystem Holdings Inc  11.10 $ 63.140  Millions$ 6  Millions
Option Care Health Inc   10.99 $ 4,561.000  Millions$ 415  Millions
Hutchmed china Limited  10.77 $ 336.349  Millions$ 31  Millions
Genedx Holdings Corp   10.51 $ 129.000  Millions$ 12  Millions
Star Equity Holdings Inc   10.28 $ 87.159  Millions$ 8  Millions
Earth Science Tech Inc   9.97 $ 7.141  Millions$ 1  Millions
Zevra Therapeutics Inc   9.73 $ 16.482  Millions$ 2  Millions
Nutriband Inc   9.68 $ 1.470  Millions$ 0  Millions
Nano X Imaging Ltd  9.44 $ 25.809  Millions$ 3  Millions
Concord Medical Services Holdings Ltd  9.43 $ 62.160  Millions$ 7  Millions
Lantheus Holdings Inc   9.29 $ 599.000  Millions$ 64  Millions
Carlsmed Inc   9.23 $ 12.110  Millions$ 1  Millions
National Vision Holdings Inc   9.22 $ 819.469  Millions$ 89  Millions
Sotera Health Company  9.20 $ 518.000  Millions$ 56  Millions
Alnylam Pharmaceuticals Inc   9.17 $ 677.166  Millions$ 74  Millions
Tarsus Pharmaceuticals Inc   9.11 $ 33.679  Millions$ 4  Millions
Warby Parker Inc   8.81 $ 401.000  Millions$ 45  Millions
Lifemd Inc   8.69 $ 27.000  Millions$ 3  Millions
Castle Biosciences Inc   8.33 $ 71.028  Millions$ 9  Millions
Myriad Genetics Inc   8.29 $ 247.000  Millions$ 30  Millions
Cardiff Lexington Corporation  8.23 $ 4.442  Millions$ 1  Millions
Collegium Pharmaceutical Inc   8.19 $ 316.071  Millions$ 39  Millions

Date modified: 2026-06-22T16:30:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.